Rankings
▼
Calendar
RGEN Q4 2017 Earnings — Repligen Corporation Revenue & Financial Results | Market Cap Arena
RGEN
Repligen Corporation
$7B
Q4 2017 Earnings
Healthcare
Medical - Instruments & Supplies
Income Statement
Revenue
$42M
+62.5% YoY
Gross Profit
$22M
54.0% margin
Operating Income
$3M
7.8% margin
Net Income
$12M
29.3% margin
EPS (Diluted)
$0.27
QoQ Revenue Growth
+13.8%
Cash Flow
Operating Cash Flow
$15M
Free Cash Flow
$13M
Stock-Based Comp.
$2M
Balance Sheet
Total Assets
$120M
Total Liabilities
$152M
Stockholders' Equity
$592M
Cash & Equivalents
$174M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$42M
$26M
+62.5%
Gross Profit
$22M
$13M
+67.3%
Operating Income
$3M
$3M
+12.3%
Net Income
$12M
$5M
+142.2%
← FY 2017
All Quarters
Q1 2018 →